VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
XXII
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
XXII22nd Century Group, Inc.
$3.90$1M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksXXIIBalance Sheet

22nd Century Group, Inc. (XXII) Balance Sheet

20Y historyFree accessUpdated daily

Financial stability remains precarious, with total equity experiencing extreme volatility and a reliance on debt-to-equity shifts to manage obligations that peaked at $16.6 million in 2024Q1.

XXII Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Sep'10Sep'09Sep'08Sep'07Sep'06
Total Current Assets21.07M17.63M11.52M16.28M44.6M54.38M28.34M42.74M61.2M67.62M16.8M7.23M10.71M7.74M1.28M971.25K2447.59K4228.12K
Cash & Short-Term Investments9.54M7.15M4.42M2.06M20.4M48.74M22.34M38.96M56.35M62.64M13.47M3.76M6.4M5.83M188252.25K2407.59K4228.12K
Cash Only9.54M7.15M4.42M2.06M2.21M1.34M1.03M485K604.92K3.66M13.47M3.76M6.4M5.83M188252.25K2407.59K4228.12K
Short-Term Investments000018.19M47.4M21.31M38.48M55.75M58.98M00000000000
Accounts Receivable4.78M3.59M2.2M1.67M1.36M585K2.16M867K871.29K957.07K40.99K51.23K46.07K49.54K40.55K23.2K04000
Days Sales Outstanding153.19186.167.5418.9412.286.928.0312.2512.0321.041.222.1931.792.48788.268.37-----
Inventory4.35M4.33M2.02M4.35M7.27M2.88M2.03M2.27M3.04M3.28M3.09M2.71M2.06M1.41M1.23M678.12K00000
Days Inventory Outstanding105.89155.0251.5138.7868.6535.6927.8332.0443.5269.2288.82108.521.51K1.11K6.61K591.9-----
Other Current Assets2.4M2.56M2.89M7.02M15.57M000928.42K746.8K00214.47K457.7K0000000
Total Non-Current Assets9.24M9.39M10.15M11.23M70.05M21.57M23.35M26.21M16.1M12.12M10.84M11.14M11.25M4.54M1.36M1.42M4.33K4.33K4.33K4.33K4.33K
Property, Plant & Equipment3.05M3.17M4.41M5.29M4.63M7.56M2.73M3.72M3.26M3.32M2.43M2.56M2.85M3M6.03K7.86K4.33K4.33K4.33K04.33K
Fixed Asset Turnover2.63x2.23x2.69x6.09x8.74x4.09x10.30x6.94x8.10x5.01x5.04x3.33x0.19x2.43x3.11x128.74x-----
Goodwill000000000000000000000
Intangible Assets6.14M4.02M5.72M5.92M7.21M7.92M8.21M8.49M9.75M7.44M7.39M7.36M7.08M1.54M1.35M1.39M00000
Long-Term Investments0000682K2.35M6.54M8.4M3.09M1.37M1.02M1.22M1.32M0004.33K4.33K4.33K4.33K4.33K
Other Non-Current Assets49K2.2M15K15K57.52M3.74M5.88M5.59M2.2M2.2M3.45M3.78M004.23K22.41K-4.33K-4.33K-4.33K0-4.33K
Total Assets30.31M27.02M21.67M27.5M114.65M75.95M51.69M68.95M77.3M79.74M27.64M18.37M21.95M12.29M2.64M2.39M4.35K4.33K11.92K4.37K32.45K
Asset Turnover0.32x0.26x0.55x1.17x0.35x0.41x0.54x0.37x0.34x0.21x0.44x0.46x0.02x0.59x0.01x0.42x-----
Asset Growth %82.5%24.69%-21.2%-76.01%50.95%46.93%-25.03%-10.8%-3.06%188.47%50.47%-16.32%78.68%364.55%10.73%54760.43%0.46%-63.64%172.67%-86.53%-
Total Current Liabilities7.91M7.27M9.96M25.03M13.02M8.43M7.34M5.78M5.17M4.31M3.25M3.24M2.67M984.33K4.6M2.87M176.95K88.8K40.92K1.23K34.13K
Accounts Payable1.02M1M2.4M4.45M2.05M2.17M1.12M2M2.57M2.08M1.34M1.28M884.41K54.66K1.41M714.89K49.8K6.18K40.92K1.23K29.03K
Days Payables Outstanding56.4835.8361.3839.6719.3726.9215.2728.2336.8243.8838.4951.46647.6543.227.58K623.996.7K----
Short-Term Debt285K372K1.75M6.39M689K596K539K581K689.15K0307.94K308.58K495.44K174.93K2.69M1.24M112.33K80K000
Deferred Revenue (Current)2.06M1.72M20K726K688K119K272K5K83.08K28.35K000179.01K0000000
Other Current Liabilities6.6M4.18M1.38M12.36M4.49M2.76M4.83M359K0216.49K00000350K00000
Current Ratio2.67x2.42x1.16x0.65x3.43x6.45x3.86x7.39x11.83x15.68x5.17x2.23x4.00x7.87x0.28x0.34x0.00x0.00x0.19x0.03x0.82x
Quick Ratio2.12x1.83x0.95x0.48x2.87x6.11x3.58x7.00x11.24x14.92x4.22x1.40x3.23x6.44x0.01x0.10x0.00x0.00x0.19x0.03x0.82x
Cash Conversion Cycle202.61305.2857.6718.0661.5715.6740.616.0518.7446.3951.5559.25896.171.07K-179.05-23.73-----
Total Non-Current Liabilities1.19M3.99M7.7M10.88M5.66M1.45M241K1.12M848.22K2.11M58.68K3.41M4.06M3.78M4.17M727K50K86.18K01.23K29.03K
Long-Term Debt475K3.24M5.17M8.06M3M00292K848.22K00307.94K605.22K0037K50K0000
Capital Lease Obligations3.09M601K1.44M1.7M711K1.43M0382K0000000000000
Deferred Tax Liabilities000000000000000000000
Other Non-Current Liabilities155K154K1.1M1.12M1.95M21K241K446K0058.68K3.1M3.46M3.78M4.17M690K00000
Total Liabilities9.09M11.27M17.66M35.91M18.68M9.88M7.58M6.9M6.02M4.31M3.31M6.64M6.73M4.76M8.78M3.6M226.95K88.8K40.92K1.23K34.13K
Total Debt1.32M4.21M8.62M16.38M4.65M2.34M786K1.48M1.54M0307.94K616.52K1.1M174.93K2.69M1.28M162.33K80K000
Net Debt-8.23M-2.94M4.2M14.32M2.45M1M-243K990K932.44K-3.66M-13.16M-3.14M-5.3M-5.66M2.69M1.03M162.3K80K-7.59K-42-28.12K
Debt / Equity0.06x0.27x2.15x-0.05x0.04x0.02x0.02x0.02x-0.01x0.05x0.07x0.02x-------
Debt / EBITDA-0.12x------------0.09x-------
Net Debt / EBITDA0.76x-------------2.89x-------
Interest Coverage-13.20x-8.03x-6.39x-4.83x-663.22x-560.98x-272.24x-473.25x-727.30x-446.67x-305.83x-207.22x-2197.39x-33.94x-3.51x-11.96x-9.39x-20.16x---
Total Equity21.22M15.76M4.01M-8.41M95.97M66.07M44.11M62.05M71.28M75.43M24.33M11.73M15.22M7.52M-6.13M-1.21M-222.6K-84.47K-29K3.15K-1.68K
Equity Growth %1975.46%292.77%147.71%-108.76%45.25%49.79%-28.91%-12.95%-5.5%209.96%107.48%-22.94%102.31%222.7%-405.81%-444.55%-163.53%-191.28%-1021.48%286.99%-
Book Value per Share35.6485.619455.02-302599.20999999.00999999.00999999.00999999.00999999.00999999.00999999.00999999.00999999.00999999.00--0.04-----
Total Shareholders' Equity21.22M15.76M4.01M-8.41M95.97M66.07M44.11M62.05M71.28M75.43M24.33M11.73M15.22M7.52M-6.13M-1.22M-222.6K-84.47K-29K3.15K-1.68K
Common Stock000002K1K1K1.25K1.24K90771064156934427317462626131
Retained Earnings-402.19M-398.93M-393.87M-378.71M-237.81M-178.01M-145.4M-125.69M-99.13M-91.17M-78.14M-66.56M-55.53M-39.93M-13.78M-7.04M-369.1K-230.97K-175.5K-93.36K-63.68K
Treasury Stock000000000000000000000
Accumulated OCI0000-111K-162K74K7K21.36K-1.24M-881.94K-555.81K-236.12K-6.1K0000000
Minority Interest0000000000000005.98K00000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Imminent liquidity and solvency

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Eroding Equity and Financial Instability

As reported in recent financial statements, 22nd Century Group's equity base has experienced extreme volatility, including periods of negative shareholder equity, which underscores the precarious nature of a balance sheet struggling to support ongoing operations amidst persistent, multi-year net losses and significant capital structure adjustments.

The trajectory of the balance sheet suggests a business model that has failed to stabilize its capital base, with equity levels fluctuating wildly due to recurring losses and potential dilutive financing. This pattern indicates that the company's financial health is highly sensitive to its inability to generate self-sustaining returns, leaving the firm in a state of perpetual vulnerability.

Leverage Dynamics Amid Capital Scarcity

Based on the company's reported figures, debt levels have fluctuated significantly, peaking at $16.6 million in 2024Q1 before declining to $1.3 million by 2026Q1, a trend that likely reflects forced deleveraging or debt-to-equity conversions rather than a strategic reduction in long-term financial obligations.

The reduction in debt appears to be a necessity-driven response to liquidity constraints rather than a sign of improved financial strength. Investors should monitor whether the company retains the capacity to access credit markets, as the current reliance on equity-based financing suggests that traditional debt instruments may no longer be viable for the firm.

Thin Cash Buffer Risks Solvency

According to quarterly filings, the company's cash position of $7.1 million as of 2025Q4 provides a limited runway, especially when evaluated against the backdrop of historical operating losses and the current ratio of 2.42, which may overstate the actual availability of liquid assets for operational needs.

The liquidity profile appears strained, as the current ratio improvement is likely driven by shifts in working capital rather than organic cash generation. Given the high burn rate, the current cash buffer may be insufficient to support the company's long-term strategic pivot without further dilutive capital raises.

Intangible Assets and Impairment Risks

As indicated in the balance sheet data, goodwill and intangible assets represent a significant portion of total assets, with $6.1 million reported in 2026Q1, raising concerns about the potential for future impairment charges if the proprietary VLN technology fails to achieve commercial scale.

The reliance on intangible assets to bolster the balance sheet suggests that the company's book value may be overstated if the underlying intellectual property does not generate expected future cash flows. This creates a hidden risk where a failure to monetize the FDA-authorized technology could lead to substantial write-downs, further eroding the company's already fragile equity position.

XXII — Frequently Asked Questions

Quick answers to the most common questions about buying XXII stock.

What are the total assets of 22nd Century Group, Inc. (XXII)?

As of 2025, 22nd Century Group, Inc. (XXII) had total assets of $27.0M including $17.6M in current assets.

How much debt does 22nd Century Group, Inc. (XXII) have?

22nd Century Group, Inc. (XXII) carries total debt of $4.2M, offset by $7.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of 22nd Century Group, Inc.?

22nd Century Group, Inc. (XXII) has total shareholders' equity (book value) of $15.8M ($85.61 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is 22nd Century Group, Inc.'s current ratio and liquidity?

22nd Century Group, Inc. (XXII) reported a current ratio of 2.42x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.